author-photo

Joan S. Brugge

Harvard University
ARIAD Pharmaceuticals, Inc.

346

Papers

44662

Citations

Citation Trend

Filter By

Papers (346) Sort By

Journal Conference Others

Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD7-03: A living biobank of normal mammary organoids derived from patients at low and increased risk of developing breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts.

2021 Oncogene
Show All
- Source
- Cite
- Save
Citations (0)
Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics

2021 Science Signaling
Show All
- Source
- Cite
- Save
Citations (0)
Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

2021 Nature Protocols
Show All
- Source
- Cite
- Save
Citations (10)
Cycling cancer persister cells arise from lineages with distinct programs.

2021 Nature
Show All
- Source
- Cite
- Save
Citations (12)
Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (1)
Characterization of Mammary Cells Co‐expressing Separate Lineage Markers

2020 The FASEB Journal
Show All
- Source
- Cite
- Save
Citations (0)
Cycling cancer persister cells arise from lineages with distinct transcriptional and metabolic programs

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (6)
Abstract P4-10-12: Characterizing the tumor and immune microenvironment through treatment to predict response to neoadjuvant HER2-targeted therapy using the Digital Spatial Profiler

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)